Application 761029
- Type
- BLA
- Sponsor
- BIOGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZINBRYTA | DACLIZUMAB | INJECTABLE;INJECTION | 150MG/ML | Yes | No |
NDC Listings For This Application#
Documents#
| Document | Submission type | Date |
|---|---|---|
| 50322 | SUPPL | 2017-11-07 |
| 49640 | SUPPL | 2017-08-31 |
| 49639 | SUPPL | 2017-08-31 |
| 49584 | SUPPL | 2017-08-30 |
| 49583 | SUPPL | 2017-08-30 |
| 48602 | SUPPL | 2017-05-31 |
| 48575 | SUPPL | 2017-05-31 |
| 48574 | SUPPL | 2017-05-31 |
| 46809 | ORIG | 2017-01-13 |
| 24537 | ORIG | 2016-07-07 |
| 23055 | ORIG | 2016-07-07 |
| 20000 | ORIG | 2016-06-01 |
| 32915 | ORIG | 2016-05-31 |